LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the Company or Second Sight), a leading developer of implantable visual prostheses that are intended to create an artificial form of useful vision for blind individuals, today announced that the Company received notice from the National Institutes of Health (NIH) of the release of year four funding for its Early Feasibility Clinical Trial of a Visual Cortical Prosthesis (the Orion Trial), grant 5UH3NS103442. The NIH released $1.1 million of the $6.4 million planned five-year grant. The Company uses the funds primarily to pay UCLA and Baylor College of Medicine to conduct the Orion Trial. The funding supports continuation of this important research and testing of the Orion Visual Cortical Prosthesis.
About the Orion Visual Cortical Prosthesis System
Leveraging Second Sights 20 years of experience in neuromodulation for vision, the Orion Visual Cortical Prosthesis System (Orion) is an implanted cortical stimulation device intended to provide useful artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. Orion is intended to convert images captured by a miniature video camera mounted on glasses into a series of small electrical pulses. The device is designed to bypass diseased or injured eye anatomy and to transmit these electrical pulses wirelessly to an array of electrodes implanted on the surface of the brains visual cortex, where it is intended to provide the perception of patterns of light. An early feasibility study of the Orion is currently underway at the Ronald Reagan UCLA Medical Center in Los Angeles and the Baylor College of Medicine in Houston. No peer-reviewed data is available yet for the Orion system.
About Second Sight Medical Products, Inc.
Second Sight Medical Products, Inc. (Nasdaq: EYES) develops implantable visual prostheses that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Companys headquarters are in Los Angeles, California. More information is available at secondsight.com. On February 4, 2022, Second Sight entered into a merger agreement with Nano Precision Medical, Inc. (NPM), and, following approval by shareholders of the Company, anticipates concluding the merger in August 2022.
Safe Harbor
This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: target, believe, expect, will, may, anticipate, estimate, would, positioned, future, intended and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Examples of forward-looking statements include, among others, statements made in this press release regarding the amount of NIH grant proceeds expected to be received. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on Second Sights current beliefs, expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, the following: (1) legal claims or proceedings relating to Second Sights termination of the Memorandum of Understanding with Pixium Vision and costs relating thereto; (2) changes in applicable laws or regulations; (3) the possibility that Second Sight may be adversely affected by other economic, business, and/or competitive factors; (4) the impact of COVID-19 on Second Sights business; (5) the possibility that shareholders of the Company may not approve the merger with NPM or that the merger may not be completed for any other reason; and (6) various other risks and uncertainties. Some of these risks and uncertainties may in the future be amplified by the COVID-19 outbreak, including subvariants thereof and there may be additional risks that Second Sight considers immaterial or which are unknown. A further list and description of risks and uncertainties can be found in Second Sights Annual Report on Form 10-K filed on March 29, 2022, and in the Companys Forms 10-K/A filed on May 2, 2022, S-4 filed on May 13, 2022, and 10-Q filed on May 16, 2022, and as thereafter amended. Any forward-looking statement made by us in this press release is based only on information currently available to Second Sight and speaks only as of the date on which it is made. Second Sight undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.
Additional Information and Where to Find It
This communication, among other things, relates to a proposed business combination of the Company and NPM. The Company filed the registration statement on Form S-4 with the Securities and Exchange Commission (the SEC), which included a document that serves as a prospectus and proxy statement of the Company. The SEC declared the registration statement effective on June 24, 2022, and the proxy statement/prospectus was first mailed to shareholders of the Company on or about June 29, 2022. The proxy statement/prospectus described above contains important information about the Company, NPM, proposed merger, and related matters. This communication is not a substitute for the proxy statement/prospectus described above. Investors and securityholders are urged to carefully read the proxy statement/prospectus and all other relevant documents filed by the Company with the SEC because they contain important information about the merger and related matters. All documents are available free of charge at the SECs website (www.sec.gov). You may also obtain these documents by contacting Companys Investor Relations department at investors@secondsight.com.
Participants of Solicitation
The Company and its respective directors and executive officers may be deemed to be participants in any solicitation of proxies in connection with the proposed merger. Information about the Companys directors and executive officers is available in the Companys Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2021. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, is contained in the proxy statement/prospectus and all other relevant materials filed with the SEC regarding the proposed merger when they become available. This document is available from the Company free of charge as described in the preceding paragraph.
Read more here:
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study - Business Wire
- Carla wants to know [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Carla wants to know [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- I believe in Renewable Energy, and here's why [Last Updated On: May 8th, 2011] [Originally Added On: May 8th, 2011]
- I believe in Renewable Energy, and here's why [Last Updated On: May 8th, 2011] [Originally Added On: May 8th, 2011]
- U.S. and Canadian Scientists Form a Global Alliance for Nano-Bio-Electronics in Order to Rapidly Find Solutions for ... [Last Updated On: February 13th, 2012] [Originally Added On: February 13th, 2012]
- Regenerative Medicine Biotech Company, Eqalix, Names Scientific Advisory Board [Last Updated On: October 9th, 2012] [Originally Added On: October 9th, 2012]
- Welcome to the body parts shop... would you like to place an order? [Last Updated On: April 15th, 2014] [Originally Added On: April 15th, 2014]
- Stem cells hold keys to body's plan [Last Updated On: June 6th, 2014] [Originally Added On: June 6th, 2014]
- InVivo Therapeutics [Last Updated On: November 12th, 2014] [Originally Added On: November 12th, 2014]
- Nanobiotechnology - Wikipedia, the free encyclopedia [Last Updated On: October 1st, 2015] [Originally Added On: October 1st, 2015]
- Center for Drug Delivery and Nanomedicine (CDDN) [Last Updated On: October 8th, 2015] [Originally Added On: October 8th, 2015]
- Nanomedicine: Nanotechnology, Biology and Medicine ... [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- Nanobiotechnology - Wikipedia [Last Updated On: November 19th, 2016] [Originally Added On: November 19th, 2016]
- Exploiting acidic tumor microenvironment for the development of novel cancer nano-theranostics - Medical Xpress [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- Nano-sized drug carriers could be the future for patients with lung disease - Phys.Org [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- Nano Medicine [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- Healthcare Nanotechnology (Nanomedicine) Market Expected to Generate Huge Profits by 2015 2021: Persistence ... - MilTech [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- Nanomedicine Research Journal [Last Updated On: September 25th, 2017] [Originally Added On: September 25th, 2017]
- Top Nanomedicine Conferences|DrugDelivery meetings ... [Last Updated On: June 29th, 2018] [Originally Added On: June 29th, 2018]
- The Promise of Nanomedicine - Laboratory Equipment [Last Updated On: July 23rd, 2018] [Originally Added On: July 23rd, 2018]
- Nanomedicine Conferences | Nanotechnology Events ... [Last Updated On: October 8th, 2018] [Originally Added On: October 8th, 2018]
- Nanomedicine - Overview [Last Updated On: October 8th, 2018] [Originally Added On: October 8th, 2018]
- IEEE-NANOMED 2016 The 10th IEEE International Conference ... [Last Updated On: October 13th, 2018] [Originally Added On: October 13th, 2018]
- Journal of Nanomedicine and Biotherapeutic Discovery- Open ... [Last Updated On: May 1st, 2019] [Originally Added On: May 1st, 2019]
- Nano-biotechnology Market by Manufacturer Analysis 2016-2024 - BitGmx [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Growing hair on bald heads with electric tech may soon be easy - Livemint [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Global Nanorobots Market Prospective Growth, Opportunities, Top Key Players and Forecast to 2024 - Pioneer Reporter [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Nanotechnology in Medical Applications Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025 - Market Forecast [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Functional Polymer Market Insights, Trends, Analysis, Types, Applications, key players, Market shares and Forecast 2019 to 2027 - The Market Plan [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Healthcare Nanotechnology (Nanomedicine) Market to Witness Growth Acceleration During 2015 2021 - Trading Herald [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Curcumin hope in TB fight - Telegraph India [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- TB vaccines with nano-curcumin work wonders - Deccan Herald [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Healthcare Nanotechnology (Nanomedicine) Market Likely To Experience High Revenue Generation In The Forthcoming Years - Commerce Gazette [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Healthcare Nanotechnology Nanomedicine Market to Witness a Pronounce Growth During 2019-2029 - Zebvo [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Self-Assembly Of Retinoid Nanoparticles For Melanoma Therapy | IJN - Dove Medical Press [Last Updated On: October 5th, 2019] [Originally Added On: October 5th, 2019]
- Improving 131I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nano | IJN - Dove Medical Press [Last Updated On: October 5th, 2019] [Originally Added On: October 5th, 2019]
- Nanorobotic Market 2019 Technological Perspective, Latest Trends and key manufacturers:: Bruker, Jeol, Thermo Fisher Scientific, Ginkgo Bioworks -... [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Quantum dots that light up TVs could be used for brain research - Stuff Magazines [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- 4 Innovative Solutions Fostering Advanced Cancer Treatment - Medical Tech Outlook [Last Updated On: October 28th, 2019] [Originally Added On: October 28th, 2019]
- Nanotechnology for disease diagnosis and treatment earns Florida Poly professor international award - Yahoo Finance [Last Updated On: November 19th, 2019] [Originally Added On: November 19th, 2019]
- Nanorobotics Market analysis and outlook for 2019-202 available in the latest report - WhaTech - WhaTech [Last Updated On: November 21st, 2019] [Originally Added On: November 21st, 2019]
- Global Next-Generation Sequencing (NGS) Market Report 2019 - World Market Projected to Surpass $25 Billion by 2026, Rising at a CAGR of 20.6% -... [Last Updated On: November 21st, 2019] [Originally Added On: November 21st, 2019]
- World Pancreatic Cancer Day: increasing awareness and inspiring action - UNSW Newsroom [Last Updated On: November 21st, 2019] [Originally Added On: November 21st, 2019]
- NanoRobotics Market Overview on Future Threats by 2026 - Crypto News Byte [Last Updated On: November 25th, 2019] [Originally Added On: November 25th, 2019]
- Nanoparticle therapy shows promise for treatment of rare cancer - The Brown Daily Herald [Last Updated On: November 25th, 2019] [Originally Added On: November 25th, 2019]
- What is the Role of Nanomedicine in Treating Melanoma? - Medical Tech Outlook [Last Updated On: January 2nd, 2020] [Originally Added On: January 2nd, 2020]
- Our top 20 features of 2019 - COVER [Last Updated On: January 5th, 2020] [Originally Added On: January 5th, 2020]
- Examine Triple Negative Breast Cancer Treatment Market expected to reach US$ 720 mn by 2026 - WhaTech Technology and Markets News [Last Updated On: January 10th, 2020] [Originally Added On: January 10th, 2020]
- Triple Negative Breast Cancer Treatment Market Combining Therapies - Communal News [Last Updated On: January 10th, 2020] [Originally Added On: January 10th, 2020]
- A Chelate-Free Nano-Platform for Incorporation of Diagnostic and Thera | IJN - Dove Medical Press [Last Updated On: January 10th, 2020] [Originally Added On: January 10th, 2020]
- VVUS Stock Jumps 70% on FDA Nod for New Formulation of Pancreaze - MicroSmallCap [Last Updated On: February 6th, 2020] [Originally Added On: February 6th, 2020]
- Is the Lieber Arrest Linked to Military Brain Research and China? - Bryen's Blog [Last Updated On: February 6th, 2020] [Originally Added On: February 6th, 2020]
- The Future Of Nano Medicine [Last Updated On: February 6th, 2020] [Originally Added On: February 6th, 2020]
- Nano Medicine: Meaning, Advantages and Disadvantages [Last Updated On: February 6th, 2020] [Originally Added On: February 6th, 2020]
- Immix Doses First Patient in USA in its Phase 1b/2a Trial in Patients with Advanced Solid Tumors - BioSpace [Last Updated On: February 11th, 2020] [Originally Added On: February 11th, 2020]
- Kanazawa University Research: Combined Drug Treatment for Lung Cancer and Secondary Tumors - Yahoo Finance [Last Updated On: February 11th, 2020] [Originally Added On: February 11th, 2020]
- Edited Transcript of NANO earnings conference call or presentation 6-Feb-20 9:30pm GMT - Yahoo Finance [Last Updated On: February 11th, 2020] [Originally Added On: February 11th, 2020]
- All your questions about how to wear a face mask -- answered - Action News Now [Last Updated On: April 26th, 2020] [Originally Added On: April 26th, 2020]
- The future of medicine - Switzer Financial News [Last Updated On: May 10th, 2020] [Originally Added On: May 10th, 2020]
- Recent Progress and Future Directions: The Nano-Drug Delivery System f | IJN - Dove Medical Press [Last Updated On: May 10th, 2020] [Originally Added On: May 10th, 2020]
- Inolife is going to revolutionize how we take our medicine - BNNBloomberg.ca [Last Updated On: May 24th, 2020] [Originally Added On: May 24th, 2020]
- Evergreen Medical Acupuncture is now offering its own supplement and herbal products, Dr. Ficks Functional Farmacy! - TippNews DAILY [Last Updated On: June 10th, 2020] [Originally Added On: June 10th, 2020]
- Impact of Covid-19 on Nano Chemotherapy Market is Expected to Grow at an active CAGR by Forecast to 2026 | Top Players Dell Wyse, IBM, Microsoft -... [Last Updated On: June 15th, 2020] [Originally Added On: June 15th, 2020]
- Kanazawa University Research: Cell Removal as the Result of a Mechanical Instability - PR Newswire UK [Last Updated On: June 15th, 2020] [Originally Added On: June 15th, 2020]
- Coronavirus threat to global Healthcare Nanotechnology (Nanomedicine) Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type... [Last Updated On: June 15th, 2020] [Originally Added On: June 15th, 2020]
- Nanocellulose Market to Reach USD 1.08 Billion by 2027 | CAGR:20.4% | Reports And Data - PRNewswire [Last Updated On: June 17th, 2020] [Originally Added On: June 17th, 2020]
- Cellics Therapeutics Announces the Publication of Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity in Nano Letters - BioSpace [Last Updated On: June 17th, 2020] [Originally Added On: June 17th, 2020]
- Opportunities in the World Nanotechnology Market to 2025 - Application of Nanotechnology in Wastewater Treatment and Enhanced Renewable Energy Driving... [Last Updated On: August 12th, 2020] [Originally Added On: August 12th, 2020]
- Interview: The NDB team on its revolutionary nano-diamond batteries - New Atlas [Last Updated On: August 29th, 2020] [Originally Added On: August 29th, 2020]
- What is Nanoscience? | Outlook and How to Invest | INN - Investing News Network [Last Updated On: September 23rd, 2020] [Originally Added On: September 23rd, 2020]
- Global Nano Therapy Market- Industry Analysis and Forecast (2020-2027) - Stock Market Vista [Last Updated On: October 29th, 2020] [Originally Added On: October 29th, 2020]
- Nanox Signs With Ambra Health to Enable Image Access and Transfer with US Hospitals and Medical imaging Providers - BioSpace [Last Updated On: October 31st, 2020] [Originally Added On: October 31st, 2020]
- Global Nanobots Market 2020 | Research Report Covers | (COVID-19 Analysis) | Industry Research, Drivers, Top Trends | Global Analysis And Forecast to... [Last Updated On: October 31st, 2020] [Originally Added On: October 31st, 2020]
- Thomas Jefferson Awards Highlight Research and Service to the University - UVA Today [Last Updated On: June 6th, 2021] [Originally Added On: June 6th, 2021]
- The Future of Cancer Treatment Using Nanotechnology - AZoNano [Last Updated On: June 6th, 2021] [Originally Added On: June 6th, 2021]
- Nanomedicine is transforming healthcare innovation - Korea IT Times [Last Updated On: June 6th, 2021] [Originally Added On: June 6th, 2021]
- Nanomedicine in Central Nervous System Injury and Repair Market Report- Trends Key Programs Analysis and Competitive Landscape Analysis The Manomet... [Last Updated On: June 23rd, 2021] [Originally Added On: June 23rd, 2021]
- Matrix Meats Adds to Team as Interest in Cultivated Meat Grows - PRNewswire [Last Updated On: July 21st, 2021] [Originally Added On: July 21st, 2021]
- Biodistribution of sphingolipid nanoemulsions with 68Ga | IJN - Dove Medical Press [Last Updated On: August 31st, 2021] [Originally Added On: August 31st, 2021]
- 2009 show based on conspiracy theories is shared as proof of WHO working on COVID-19 vaccines to create permanent sterility - Factly [Last Updated On: January 5th, 2022] [Originally Added On: January 5th, 2022]